Event details

Thank you for your interest in this non-promotional medical education webinar initiated, organised, developed and funded by Madrigal for HCPs only on Wednesday 23rd September 2026 from 19:00–20:00 BST.


This webinar will provide practical insights into the use of non-invasive tests (NITs) and guideline-informed approaches to support earlier identification, risk stratification and referral of patients with suspected metabolic dysfunction-associated steatohepatitis (MASH) within local clinical pathways.


Meeting objectives

  • Recognise the progression and risk factors for fibrosis in MASH and impact of metabolic dysfunction
  • Incorporating NITs into clinical practice
  • Understand the local referral and management pathway in Bristol, North Somerset & South Gloucestershire Integrated Care System (ICS)
This webinar has been approved by the Faculty of Pharmaceutical Medicine for 1 CPD point.


Meeting agenda

19:00−19:05

Welcome and Introductions

19:05−19:10

MASH Background and Unmet Needs

19:10−19:20

International Guidelines for the Management of MASLD/MASH

19:20−19:30

Assessment and Diagnosis of MASH

19:30−19:40

Local Pathways and Considerations

19:45−20:00

Q&A

MASH; Metabolic Dysfunction-Associated Steatohepatitis
MASLD; Metabolic Dysfunction-Associated Steatotic Liver Disease

Discover resources to help strengthen identification, risk stratification and service delivery in MASH care. Scan the QR code or visit Madrigal Connect to explore practical tools and examples.

Madrigal Connect QR Code

Register

We will process your personal data (including your name, professional contact details, specialty, and congress participation) for the purposes of managing our interactions with you and for our legitimate business purposes, including maintaining and updating our healthcare professional (HCP) relationship management database (CRM).

Further information on why and how we process your personal data, our legal basis for doing so, including details of your rights and how to exercise them, is available in our HCP Privacy Notice. You may object at any time to the processing of your personal data as described in the HCP Privacy Notice.

ConnectDNA Group Ltd is a third-party agency engaged in the management and logistical arrangements of this webinar on behalf of Madrigal Pharmaceuticals. By registering for this meeting, you consent to ConnectDNA Group Ltd to use the personal information provided within this registration website for the purposes of keeping you informed of this meeting only.

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.
* Required Fields